Objective and design: Some studies suggest that specific hormonal contraceptive methods
[particularly depot medroxyprogesterone acetate (DMPA)] may increase women's HIV …

The major burden of the human immunodeficiency (HIV) type 1 pandemic is nowadays
carried by women from sub-Saharan Africa. Differences in the manifestations of HIV-1 …

Background Estimates of sexually transmitted infection (STI) prevalence are essential for
efforts to prevent and control STIs. Few large STI prevalence studies exist, especially for low …

Medical Eligibility Criteria for Contraceptive Use reviews the medical eligibility criteria for
use of contraception, offering guidance on the safety and use of different methods for women …

Background Observational studies of a putative association between hormonal
contraception (HC) and HIV acquisition have produced conflicting results. We conducted an …

Objective: To develop and validate an HIV risk assessment tool to predict HIV acquisition
among African women. Design: Data were analyzed from 3 randomized trials of biomedical …

Background The evidence from epidemiological research into whether use of hormonal
contraception increases women's risk of HIV acquisition is inconsistent. We did a robust …

Background The use of injectable progestin-only contraceptives has been associated with
increased risk of HIV acquisition in observational studies, but the biological mechanisms of …

Whether use of various types of hormonal contraception (HC) affect risk of HIV acquisition is
a critical question for women's health. For this systematic review, we identified 22 studies …

Whether or not the use of hormonal contraception affects risk of HIV acquisition is an
important question for public health. We did a systematic review, searching PubMed and …